Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2023-06-21 00:00:00 ET · period of report 2023-06-20 · accession 0001104659-23-073400 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-21 | 2023-06-20 | AMPH | Zhou Rong | EVP, Production Center | M - OptEx | $11.33 | +9,651 | 112.3K | +9% | +$109.3K |
| D | 2023-06-21 | 2023-06-20 | AMPH | Zhou Rong | EVP, Production Center | M - OptEx | $0.00 | -9,651 | 24.8K | -28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-20 | M | A | 9,651 | $11.33 | 112,341 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-06-20 | M | D | 9,651 | $0.00 | 24,787 | D | $11.33 · — to 2026-03-17 | 9,651 Common Stock | (F3) Shares subject to the option are fully vested and immediately exercisable. |